Upstream Bio, Inc. Common Stock

UPB

Upstream Bio, Inc. (UPB) is a biopharmaceutical company focused on developing novel therapies for immune-mediated diseases. The company aims to address unmet medical needs by advancing innovative treatments through optimized clinical development and strategic partnerships.

$26.11 +0.55 (2.17%)
🚫 Upstream Bio, Inc. Common Stock does not pay dividends

Company News

Upstream Bio to Participate in Upcoming November Investor Conferences
GlobeNewswire Inc. • Meggan Buckwell • October 31, 2025

Upstream Bio, a clinical-stage biotechnology company, will participate in multiple investor conferences in November 2025, presenting its research on verekitug, a potential treatment for inflammatory respiratory diseases.

Related Companies

Wheels Up Experience Inc.
Wheels Up Experience Inc.
UP
UPAR Ultra Risk Parity ETF
UPAR Ultra Risk Parity ETF
UPAR
Universe Pharmaceuticals Inc. Ordinary Shares
Universe Pharmaceuticals Inc. Ordinary Shares
UPC
Upbound Group, Inc. Common Stock
Upbound Group, Inc. Common Stock
UPBD